The FGF family: biology, pathophysiology and therapy

By A. Beenken, M. Mohammadi. Nature reviews. Drug discovery, 2009

1,857 citations recorded by the source corpus.

The family of fibroblast growth factors (FGFs) regulates a plethora of developmental processes, including brain patterning, branching morphogenesis and limb development. Several mitogenic, cytoprotective and angiogenic therapeutic applications of FGFs are already being explored, and the recent discovery of the crucial roles of the endocrine-acting FGF19 subfamily in bile acid, glucose and phosphate homeostasis has sparked renewed interest in the pharmacological potential of this family. This Review discusses traditional applications of recombinant FGFs and small-molecule FGF receptor kinase inhibitors in the treatment of cancer and cardiovascular disease and their emerging potential in the treatment of metabolic syndrome and hypophosphataemic diseases.

Subfields: Genetics, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/8e6d18e58bf57b2e0f053b8663d9c2301c707820

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

  1. N. Itoh
  2. D. Ornitz
  3. M. Roy
  4. A. Bandyopadhyay
  5. Peter Carmeliet
  6. Rakesh K. Jain
  7. S. Bose
  8. M. Mohammadi

In Molecular Biology

  1. Rakesh K. Jain
  2. Peter Carmeliet
  3. N. Itoh
  4. D. Ornitz
  5. N. Ferrara
  6. J. Joyce
  7. Dai Fukumura
  8. Triantafyllos Stylianopoulos

Citations in the corpus